Cargando…
SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer
Introduction: SRPX2 and RAB31 play important roles in tumorigenesis and metastasis; however, their prognostic value in pancreatic cancer remains unclear. This study aimed to investigate the potential interactions and effects of SRPX2 and RAB31 on the diagnosis and prognosis of pancreatic cancer. Met...
Autores principales: | Li, Hao, Zhang, Shi-Rong, Xu, Hua-Xiang, Wang, Wen-Quan, Li, Shuo, Li, Tian-Jiao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang, Wu, Chun-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584922/ https://www.ncbi.nlm.nih.gov/pubmed/31258775 http://dx.doi.org/10.7150/jca.32072 |
Ejemplares similares
-
SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
por: Gao, Zhenyuan, et al.
Publicado: (2020) -
Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer
por: Xu, Shuai-Shuai, et al.
Publicado: (2020) -
SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma
por: Ampudia-Mesias, Elisabet, et al.
Publicado: (2022) -
The Significance of Liquid Biopsy in Pancreatic Cancer
por: Qi, Zi-Hao, et al.
Publicado: (2018) -
High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer
por: Zhang, Meng, et al.
Publicado: (2018)